Compact Biomedical ApS: Financial statements 2020
CVR: 32780601
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Compact Biomedical ApS (CVR 32780601) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -6,101 and a net result of DKK -4,266,584 compared with DKK -1,135,854 the year before. Equity in the 2020 report amounted to DKK 519,412. The solvency ratio was 7.8%.
- Gross Profit
- DKK -6,101
- Profit/Loss
- DKK -4,266,584
- Equity
- DKK 519,412
- Total Assets
- DKK 6,640,885
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -6 t. | -4.3 mio. | 519 t. | - |
| 2019 | - | -6 t. | -1.1 mio. | 4.8 mio. | - |
| 2018 | - | -5 t. | -964 t. | 5.9 mio. | - |
| 2017 | - | -5 t. | -1 mio. | 6.9 mio. | - |
| 2016 | - | -5 t. | 1.7 mio. | 7.9 mio. | - |
Official annual report
How creditworthy is Compact Biomedical ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Compact Biomedical ApS has published its annual report for 2019. Gross profit came to DKK -6,126, and the net result was DKK -1,135,854.
About Compact Biomedical ApS
Compact Biomedical ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Sten Velschow. The company is owned by Sten Velschow. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 60,971 and a net result of DKK 48,494 compared with DKK -36,656 the year before. Equity in the 2025 report amounted to DKK -81,224.